2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Arthritis care & research | 18 Jun 2017
SM Goodman, B Springer, G Guyatt, MP Abdel, V Dasa, M George, O Gewurz-Singer, JT Giles, B Johnson, S Lee, LA Mandl, MA Mont, P Sculco, S Sporer, L Stryker, M Turgunbaev, B Brause, AF Chen, J Gililland, M Goodman, A Hurley-Rosenblatt, K Kirou, E Losina, R MacKenzie, K Michaud, T Mikuls, L Russell, A Sah, AS Miller, JA Singh and A Yates
This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA).
* Data courtesy of Altmetric.com